Gefitinib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Summary

Biological therapies such as gefitinib may interfere with the growth of the tumor cells and slow the growth of glioblastoma multiforme. Phase II trial to study the effectiveness of gefitinib in treating patients who have newly diagnosed glioblastoma multiforme.

Timeline

Start

2001-03

Primary completion

2003-07

Completion

—

Drugs

Indications